ESSA Pharma Inc.
ESSA Pharma Inc.:
In Ph1 with a small molecule drug targeting the n-terminal domain of the androgen receptor. Potential for treatment post-current AR therapies and in combination in earlier lines. Pfizer participated in most recent fundraising.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
North America
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Men's Health, Oncology
Listing
Public, USA
Market Cap
500MM - 1B
Website:
Profiles:
Address:
999 West Broadway Street Suite 720
Vancouver, BC BC V5Z 1K5
Canada
Vancouver, BC BC V5Z 1K5
Canada
More info:
My account:
Company Participants at Solebury Trout Virtual Management Access Event 2021
David Parkinson
ESSA Pharma Inc., President/CEO
Served as President and CEO of ESSA Pharma Inc. since January 2016, and as Director of the company since June 2015. Prior to joining ESSA he was a Venture Partner at New Enterprise Associates. From 2007-2012, he served as President & CEO of Nodality, Inc. Until October 2007 he was SVP, Oncology Research and Development at Biogen Idec. Previously he served as VP, Oncology Development, at Amgen and VP, Global Clinical Oncology Development at Novartis.
Top 10 Holders of ESSA Pharma Inc
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| BVF, Inc. | 17.79 | 3,705,289 | 111.71 | 13F | 12/31/20 |
| BVF Partners LP | 17.79 | 3,705,289 | 111.71 | Stakes | 12/31/20 |
| Clarus Ventures LLC | 17.16 | 3,573,053 | 107.73 | 13F | 12/31/20 |
| Avidity Partners Management LP | 12.28 | 2,558,000 | 77.12 | 13F | 12/31/20 |
| Soleus Capital Management LP | 11.41 | 2,375,681 | 71.63 | 13F | 12/31/20 |
| Soleus Capital Management LP (Investment Management) | 11.41 | 2,375,681 | 71.63 | Stakes | 12/31/20 |
| Eventide Asset Management LLC | 11.21 | 2,335,168 | 70.41 | Stakes | 12/31/20 |
| Vivo Capital LLC | 9.09 | 1,893,907 | 57.10 | 13F | 12/31/20 |
| Bellevue Asset Management AG | 8.77 | 1,825,814 | 55.05 | Funds | 3/31/21 |
| Driehaus Capital Management LLC | 5.03 | 1,048,524 | 31.61 | Stakes | 12/31/20 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.